deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT01013714

Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias (PREVENT VT)

Prophylactic Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias (PREVENT VT)

Sponsor: Oregon Health and Science University

Conditions Cardiomyopathy Sudden Cardiac Death Ventricular Fibrillation Ventricular Tachycardia
Interventions Cardiac Sympathetic Denervation (CSD) Routine Care
Updated 17 times since 2017 Last updated: Jan 17, 2024 Started: Jul 26, 2021 Primary completion: Aug 31, 2024 Completion: Aug 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01013714, this PHASE3 trial focuses on Cardiomyopathy and Sudden Cardiac Death and remains ongoing. Sponsored by Oregon Health and Science University, it has been updated 17 times since 2021, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Nov 2019 · 12 months · monthly snapshot~Nov 2019 – ~Sep 2020 · 10 months · monthly snapshot~Sep 2020 – ~Dec 2020 · 3 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Feb 2023 · 16 months · monthly snapshot~Feb 2023 – ~Dec 2023 · 10 months · monthly snapshot~Dec 2023 – ~Feb 2024 · 2 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

17 versions recorded

  1. Feb 2026 — Present [monthly]

    Unknown PHASE3

    Status: Recruiting → Unknown

  2. Sep 2024 — Feb 2026 [monthly]

    Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  4. Feb 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

  5. Dec 2023 — Feb 2024 [monthly]

    Recruiting PHASE3

▶ Show 12 earlier versions

  1. Feb 2023 — Dec 2023 [monthly]

    Recruiting PHASE3

  2. Oct 2021 — Feb 2023 [monthly]

    Recruiting PHASE3

  3. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. Apr 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE3

  5. Jan 2021 — Apr 2021 [monthly]

    Not Yet Recruiting PHASE3

  6. Dec 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

  7. Sep 2020 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE3

  8. Nov 2019 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE3

  9. Nov 2018 — Nov 2019 [monthly]

    Not Yet Recruiting PHASE3

  10. Jun 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE3

  11. Jun 2017 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

  12. Jan 2017 — Jun 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oregon Health and Science University
  • University of California, Los Angeles
Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations